125057-00-3 Usage
Chemical structure
A pyrimidine derivative with two phenylsulfanyl groups attached to the 5 and 6 carbon atoms, and a 1-(2-hydroxyethoxy)methyl group attached to the 1 carbon atom.
Functional groups
Hydroxyl (-OH), phenylsulfanyl (-SPh), and carbonyl (C=O) groups.
Potential applications
Pharmaceutical applications due to its structure, which could potentially be involved in biological activities such as enzyme inhibition, receptor binding, or other biological interactions.
Further investigation
The specific properties and uses of 1-[(2-hydroxyethoxy)methyl]-5,6-bis(phenylsulfanyl)pyrimidine-2,4(1H,3H)-dione would need to be further investigated through chemical and biological studies.
Check Digit Verification of cas no
The CAS Registry Mumber 125057-00-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,5,0,5 and 7 respectively; the second part has 2 digits, 0 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 125057-00:
(8*1)+(7*2)+(6*5)+(5*0)+(4*5)+(3*7)+(2*0)+(1*0)=93
93 % 10 = 3
So 125057-00-3 is a valid CAS Registry Number.
125057-00-3Relevant academic research and scientific papers
6-substituted acyclopyrimidine nucleoside derivatives and antiviral agents containing the same as active ingredient thereof
-
, (2008/06/13)
6-substitutted acyclopyrimidine nucleoside derivatives represented by the following general formula I: STR1 wherein R1 represents a hydrogen or halogen atom or a group of alkyl, alkenyl, alkynyl, alkylcarbonyl, arylcarbonyl, arylcarbonylalkyl,
A new class of HIV-1-specific 6-substituted acyclouridine derivatives: Synthesis and anti-HIV-1 activity of 5- or 6-substituted analogues of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT)
Tanaka,Baba,Hayakawa,Sakamaki,Miyasaka,Ubasawa,Takashima,Sekiya,Nitta,Shigeta,Walker,Balzarini,De Clercq
, p. 349 - 357 (2007/10/02)
A series of novel acyclouridine derivatives substituted at both the C-5 and C-6 positions were synthesized for the purpose of improving the activity of a recently reported HIV-1-specific lead, 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT). Prep